{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:48:16Z","timestamp":1762177696418,"version":"3.37.3"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jneuroim.2024.578397","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:57:19Z","timestamp":1718931439000},"page":"578397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluating the effect of dimethyl fumarate on subclinical biomarkers in a real-world patient cohort"],"prefix":"10.1016","volume":"393","author":[{"given":"Stephen","family":"Krieger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myassar","family":"Zarif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bumstead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijean","family":"Buhse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno","family":"Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Sima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemie","family":"Ribbens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Van Hecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason P.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Gudesblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2024.578397_bb0005","doi-asserted-by":"crossref","DOI":"10.1007\/s12325-018-0805-y","article-title":"interpretation and impact of real-world Clinical data for the practicing clinician","author":"Blonde","year":"2018","journal-title":"Adv. Ther."},{"issue":"23","key":"10.1016\/j.jneuroim.2024.578397_bb0010","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/WNL.0b013e3181e24136","volume":"74","author":"De Stefano","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jneuroim.2024.578397_bb0015","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1212\/CPJ.0000000000000238","article-title":"Characterizing absolute lymphocyte count profiles in dimethyl fumarate\u2019treated patients with MS Patient management considerations","volume":"6","author":"Fox","year":"2016","journal-title":"Neurol. Clin. Pract."},{"issue":"6","key":"10.1016\/j.jneuroim.2024.578397_bb0020","article-title":"Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years\u2019 follow-up of DEFINE, CONFIRM, and ENDORSE","volume":"13","author":"Gold","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jneuroim.2024.578397_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.809273","article-title":"Effects of Dimethyl Fumarate on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: Pooled Analysis Phase 3 DEFINE and CONFIRM Studies","volume":"13","author":"Nakamura","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578397_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102707","article-title":"icobrain ms 5.1: Combining unsupervised and supervised approaches for improving the detection of multiple sclerosis lesions","volume":"31","author":"Raki\u0107","year":"2021","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.jneuroim.2024.578397_bb0035","first-page":"542","article-title":"MSmetrix validation of normative brain volume population graphs to serve as a reference in the clinical follow up of MS patients","volume":"22","author":"Sima","year":"2016","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jneuroim.2024.578397_bb0040","article-title":"Age-dependent whole brain and grey matter annual atrophy rates in healthy adults","volume":"23","author":"Sima","year":"2017","journal-title":"Mult. Scler. J."},{"issue":"5","key":"10.1016\/j.jneuroim.2024.578397_bb0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/cts.12559","article-title":"innovation at the Intersection of clinical trials and real-world data science to advance patient care","volume":"11","author":"Swift","year":"2018","journal-title":"Clin. Trans. Sci."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824001152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824001152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T19:33:34Z","timestamp":1728156814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572824001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":9,"alternative-id":["S0165572824001152"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578397","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the effect of dimethyl fumarate on subclinical biomarkers in a real-world patient cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578397"}}